In many ways, the pitch night in Kendall Square on Wednesday was business as usual. Founders presented their young biopharma and medical device companies to investors, promising they could someday take away people’s pain, capture markets — even save lives.
But one thing was noticeably different: All ten of the presenters were women.
About the Author Reprints
